Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites.

Guangqi Gao,Siyuan Shen,Tao Zhang,Jiachao Zhang,Shi Huang,Zhihong Sun,Heping Zhang

EBioMedicine（2023）

引用 3|浏览40

暂无评分

摘要

This research was supported by Research Fund for the National Key R&D Program of China (2022YFD2100702), Inner Mongolia Science and Technology Major Projects (2021ZD0014), and China Agriculture Research System of MOF and MARA.

查看译文

关键词

Anti-PD-1,Gut microbiota,Lacticaseibacillus rhamnosus Probio-M9,Probiotics,Synergistic anti-tumor therapeutics,α-ketoglutaric acid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要